GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing

GeneDx announces that the FDA has granted Breakthrough Device Designation for its whole genome and exome tests.
Business Wire

Whole Exome Sequencing Market Research Report 2024-2034: Adoption in Clinical Diagnostics, Integration with AI and Bioinformatics, & Increasing Focus on Precision Medicine ...

DUBLIN--(BUSINESS WIRE)--The "Whole Exome Sequencing Market - A Global and Regional Analysis: Focus on Product, Workflow, Application, End User, and Country - Analysis and Forecast, 2024-2034" report ...
The American Journal of Managed Care

Whole Exome Sequencing Identifies Distinct Profile of Transformed SCLC

Transformed SCLC from EGFR-mutated LUAD shows a unique mutational profile, complicating treatment approaches and highlighting the need for tailored therapies. Whole exome sequencing revealed ...

GeneDx's Blueprint For The Next Healthcare Revolution

GeneDx Holdings (WGS) is poised for growth with strong Q2 results and SaaS transition. Read here for an investment analysis.
GEN

Integrative Exome Sequencing and Machine Learning Identify New Genes Contributing to Systemic Sclerosis Risk

Scientists at the Baylor College of Medicine and collaborating institutions used complementary approaches that integrate exome sequencing and evolutionary action machine learning to identify protein ...

Baylor Genetics Presents New Data on Clinical and Diagnostic Utility of RNA Sequencing for Rare Disease at the American Society of Human Genetics 2025 Annu…

Research underscores clinical utility of RNA sequencing in providing critical insights to drive diagnoses and medical ...

Caris Life Sciences, Inc. (CAI) Soars 81% YoY with $181M Q2 Revenue

We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. Caris Life Sciences, Inc. is one of them. Caris Life Sciences, Inc. (NASDAQ:CAI) is advancing its position as a ...

Baylor Genetics to Showcase Clinical and Diagnostic Utility of Genome Sequencing and Multi-omics Across Rare Disease at the American Society of Human Genetics 2025 Annual Meeting

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced it will showcase its leadership in genome sequencing and multi-omics to uncover critical ...
Baylor College of Medicine

Integrative exome sequencing and machine learning identify new genes contributing to systemic sclerosis risk

Systemic sclerosis (SSc) is a severe autoimmune disease with complex genetic causes. Some genetic contributors have been identified, but others remain unknown, which has impeded development of ...